ClinicalTrials.Veeva

Menu

Effect of the Stellate Ganglion Block on the Retinal Microcirculation

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Enrolling

Conditions

Subarachnoid Hemorrhage
Severe Brain Injury
Intracerebral Hemorrhage
OCTA

Treatments

Device: OCTA Scan

Study type

Observational

Funder types

Other

Identifiers

NCT06797752
STU-2024-1027

Details and patient eligibility

About

Surges in the sympathetic nervous system occur at the ictus of a variety of neurological critical illnesses including intracranial hemorrhage and ischemic stroke. It is hypothesized that these exaggerated increases in sympathetic nervous activity produce maladaptations that promote secondary brain injury. One of these possible mechanisms include diffuse vasospasm that cause cerebral ischemia. Hence, methods to abrogate the sympathetic nervous system in this context are under active investigation. One possible method is the regional anesthesia technique of the stellate ganglion nerve block, which is ordinarily used for complex regional pain syndrome, but has been shown to reduce cerebral sympathetic activity and reduces vasospasm in patients with subarachnoid hemorrhage. However, its effect on the microcirculation is not clear. Hence, we propose to study patients receiving the stellate ganglion nerve block as part of their standard medical care and to image their retinal microcirculation before and after the procedure using Optical Coherence Tomography Angiography (OCTA).

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 years or older
  • Patients receiving the stellate ganglion nerve block for an approved indication, e.g. complex regional pain syndrome

Exclusion criteria

  • Pregnancy
  • Non-English speaking
  • Temporary or permanent physical limitation that renders the patient unable to sit up and look inside OCTA device

Trial design

50 participants in 1 patient group

Intervention Group
Description:
Patients receiving the stellate ganglion block
Treatment:
Device: OCTA Scan

Trial contacts and locations

1

Loading...

Central trial contact

Noah Jouett, DO, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems